Slide 1: Investor Presentation
Investor Presentation May 2025 NASDAQ: LFMD
Slide 2: Important cautions regarding forward-looking statements
2 Important cautions regarding forward-looking statements This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the U.S. Priva
Slide 3: Building the leading platform for comprehensive virtual healthcare
3 Building the leading platform for comprehensive virtual healthcare 1.2M Virtual Consults Conducted End-to-end, compliance-first platform for direct-to-consumer virtual primary care Early-mover advantage and partnership strategy create a deep 290,000 Active Patients competitive moat Affiliated 50-s
Slide 4: Investment highlights
4 Investment highlights Proven ability to operate at scale within large and growing addressable markets thanks to robust infrastructure Differentiated, end-to-end technology platform and affiliated medical group supporting complex virtual primary care needs of 800-1,000 new patients per day Signific
Slide 5: Telehealth can solve many of the biggest problems facing the U.S. healthcare system
5 Telehealth can solve many of the biggest problems facing the U.S. healthcare system Need Solution 1/3 of Americans don’t have a primary care doctor, and At LifeMD, providers are available 24/7, with <1 hour Timeliness the average wait time to see a family doctor is 20.6 appointment wait time days.
Slide 6: A $170 billion total addressable market in the U.S.
6 A $170 billion total addressable market in the U.S. LifeMD’s virtual care platform is addressing unmet needs in primary care and specialized healthcare. Male and Female Sexual Health Insomnia U.S. Primary Care Market Weight Management Mental Health & Wellness $170B Diabetes Management Hormone Ther
Slide 7: LifeMD has built an end-to-end platform for comprehensive virtual healthcare
7 LifeMD has built an end-to-end platform for comprehensive virtual healthcare Patient Acquisition Diagnostics Internal creative, online/offline media Integrations with Quest & LabCorp and buying, SEO, and CRM platform in-home collection Business Intelligence Telehealth Data & analytics platform to
Slide 8: Technology designed to provide best-in-class experience and care for all stakeholders
8 Technology designed to provide best-in-class experience and care for all stakeholders For Patients For Providers For Partners For Industry Patients benefit from an intuitive virtual Streamlined workflow optimization with Flexible partnerships with unique Life sciences companies who partner care pl
Slide 9: Our affiliated medical group, staffed by full-time providers, is central to our success
9 Our affiliated medical group, staffed by full-time providers, is central to our success 99% 1.2M 200+ 4.9/5 Of consults start on Consults completed Different conditions Average physician rating time* LifeMD treats Dr. Puopolo 98% 50 President, LifeMD Affiliated Medical Group Patients satisfied wit
Slide 10: Our success is driven by three core pillars
10 Our success is driven by three core pillars DTC Telemedicine Virtual Primary Care B2B Solutions Subscription-based treatment and Services include primary care, Digital front-door strategies for Rx Offerings urgent care, and chronic condition healthcare product companies management Established, wh
Slide 11: Our track record of strategic focus and growth
11 Our track record of strategic focus and growth November Launch affiliated nationwide JUNE pharmacy Commenced tech build for JUNE LifeMD Virtual Primary Care December 2023 (VPC) platform Executed $20M Acquired cloud –based telehealth technology collaboration agreement MAY platform with Medifast Cr
Slide 12: Clear strategy focused on scaling high-value revenue streams
12 Clear strategy focused on scaling high-value revenue streams Key Priorities Goals Virtual Primary Care Continue to scale weight management/GLP-1 offering High Value Revenue Streams With Long-Term Brand Equity Launch behavioral health and women's health offerings Offer commercial health insurance
Slide 13: Our management team has deep experience leading innovative healthcare organizations
13 Our management team has deep experience leading innovative healthcare organizations Justin Schreiber Marc Benathen Stefan Galluppi Jessica Friedeman Chief Executive Officer Chief Financial Officer Chief Innovation Chief Marketing Officer & Chairman Officer Eric Yecies Dennis Wijnker Nick Alvarez
Slide 14: Our businesses have experienced rapid, consecutive YoY Growth
14 $272M Our businesses have experienced rapid, $212M consecutive YoY Growth $60M $152M $54M $272M 2025E Revenue Forecast $54M $119M $93M $36M 28% $212M Forecast 2025 Growth $25M Rate Versus 2024 $158M $98M $83M $37M $68M 1.2M $13M $7M $30M Patients & $2M $11M Customers To-Date 2019A 2020A 2021A 202
Slide 15: Rapid and sustainable profitability growth in our core telehealth business
15 Rapid and sustainable profitability growth in our core telehealth business Annual telehealth adjusted EBITDA ($ millions) $21M $7.4M $(4.5)M 2024A 2025E $(19.5)M 2023A ($35.8)M 2022A 2021A Note: adjusted EBITDA includes Telehealth only results. 2025 Estimate based on FY2025 guidance provided by C
Slide 16: Rapidly expanding telehealth gross margins and ad spend leverage
16 Rapidly expanding telehealth gross margins and ad spend leverage driven by patient retention are driving telehealth profitability growth Telehealth Gross Margin % Telehealth Ad Spend % of Revenue 90% 90% 80% 80% 70% 70% 60% 60% 50% 50% 40% 40% 30% 30% 20% 20% 10% 10% 0% 0% 2021 2022 2023 2024 YTD
Slide 17: WorkSimpli is a highly profitable asset with a strong cash flow profile
WorkSimpli is a highly profitable asset with a strong cash flow profile Global provider of Workplace and document Software-as-a-Service offerings to consumers and small businesses specializing in the pdf, resume/ HR, digital signature and forms markets Over 158,000 subscribers with platform availabl
Slide 18: 2025 guidance reflects substantial growth in revenue and profitability
18 2025 guidance reflects substantial growth in revenue and profitability FY 2025 GUIDANCE FY 2024 ACTUAL DELTA Telehealth Revenue $208 to $213 million $158 million +32% to +34% WorkSimpli Revenue $60 to $62 million $54 million +11% to +15% Consolidated Revenue $268 to $275 million $212 million +26%
Slide 19: In summary
19 In summary Significant presence within established and growing addressable markets Proprietary technology platform differentiated by leading 50-state, affiliated physician network High margin products/services generating 85%+ consolidated gross margins Powerful telehealth infrastructure enabling
Slide 20: Appendix
Appendix LifemD*
Slide 21: Reconciliation of GAAP Net Loss to Adjusted EBITDA
21 Reconciliation of GAAP Net Loss to Adjusted EBITDA (in whole numbers, unaudited) (a) For the three months ended March 31, 2025, the Company included litigation costs related to a heavily negotiated executiv e separation agreement. For the three months ended March 31, 2024, the Company included co
Slide 22: Reconciliation of Telehealth GAAP Operating Loss to Telehealth Adjusted EBITDA
22 Reconciliation of Telehealth GAAP Operating Loss to Telehealth Adjusted EBITDA (in whole numbers, unaudited) (a) For the three months ended March 31, 2025, the Company included litigation costs related to a heavily negotiated executiv e separation agreement. For the three months ended March 31, 2
Slide 23: Reconciliation of WorkSimpli GAAP Operating Income to WorkSimpli Adjusted EBITDA
23 Reconciliation of WorkSimpli GAAP Operating Income to WorkSimpli Adjusted EBITDA (in whole numbers, unaudited)
Slide 24: Company Contact
Company Contact Marc Benathen marc@lifemd.com Media Contact press@lifemd.com